ABSTRACT
INTRODUCTION
Aflatoxins are well recognized as a cause of liver cancer, but they have additional important toxic effects. In farm and laboratory animals, chronic exposure to aflatoxins compromises immunity and interferes with protein metabolism and multiple micronutrients that are critical to health. These effects have not been widely studied in humans, but the available information indicates that at least some of the effects observed in animals also occur in humans (1) . Aflatoxin is a common contaminant of foods, particularly in the staple diets of many developing countries. The toxicity of aflatoxin also varies according to many nutritional factors (2) and recovery from protein malnutrition is delayed by exposure to aflatoxin (3, 4) .
Conventional or synthetic drugs used in the treatment of liver diseases are sometimes inadequate and can have serious adverse effects. So there is a worldwide trend to go back to traditional medicinal plants. Many natural products of herbal origin are used for the treatment of liver ailments. Drug induced hepatotoxicity is a potentially serious adverse effect of the currently used antitubercular chemotherapeutic regimens containing isoniazide, aflatoxin and pyrazinamide. It has been established in experimental animals that antitubercular drugs administered in toxic doses affect the liver, its membranes and organelles. This is supported by release of aspartate and alanine aminotransferases and alkaline phosphatase in serum (5, 6) .
Trianthema portulacastrum L. (Family: Aizoaceae) is a prostrate, glabrous, succulent annual found almost throughout India as a weed in cultivated and wastelands. The plant is bitter, hot, alexiteric, analgesic, stomachic, laxative and serves as alterative cures for bronchitis, heart disease, blood anaemia, inflammation and piles ascites (7) . The root applied to the eye cures corneal ulcers, itching, dimness of sight and night blindness (8) . A decoction of the herb is used as a vermifuge and is useful in rheumatisms. It is also an antidote to alcoholic poison (9) and has remarkable effect in the reduction of DENA-induced hepatocarcinogenesis (10), antioxidant effect (11) and lowering effect of paracetamol and thioacetamide induced hepatotoxicity in rats (12) . The bitter and nauseous root is given in combination with ginger as a cathartic (8) . The present study was undertaken to evaluate the effect of ethanolic leaf extract of Trianthema portulacastrum on hepato-marker enzymes as well as on histomorphological changes in the liver against aflatoxin-induced hepatotoxicity.
MATERIALS AND METHODS
The leaf of Trianthema portulacastrum L. was collected during Jan-Feb.2002 from Tiruchirapalli, Tamilnadu, India. The plant was authenticated by comparison with reference specimens preserved at the Rapinat Herbarium of St. Joseph's College, Tiruchirapalli. Voucher Herbarium Specimens (Collection number 299, 300, 6711, 12114, 26644) are kept in the Herbarium for future references.
Coarse powder from the shadow dried leaf of T. portulacastrum L. (500 g) was extracted to exhaustion with ethanol using a soxhlet apparatus. The ethanolic extract thus obtained was dried under reduced pressure at a room temperature not exceeding 40°C to get 100 g of the crude extract.
The study was carried out on mixed sex of Wistar albino rats (100-150 g). The rats bred in Bharathidasan University, Tiruchirapalli were used. They were fed with a standard pellet (Lipton India Ltd., Calcutta) and water ad libitum. The rats were kept in standard environmental conditions (temperature 25-28° C and 12 h light/12 h dark cycle).
Rats were divided into control, aflatoxin and test (aflatoxin + ethanolic leaf extracts of T. portulacastrum) groups. Aflatoxin suspended in 5% acacia was administered 1mg/kg body weight, per oral (p.o.) (13) . The control group of rats received 5% w/v acacia mucilage (1ml/kg b.w, p.o.) four times at 12 hr intervals. The aflatoxin group of rats received 5% w/v acacia mucilage (1ml/kg b.w, p.o.) four times at 12 hr intervals and a single dose of aflatoxin 1mg/kg, 30 minutes after the administration of first dose of acacia mucilage. The test groups received ethanolic leaf extracts of T. portulacastrum (50-800 mg/kg b.w, p.o.) four times at 12 hr intervals. Aflatoxin (1mg/ kg b.w, p.o.) was administered 30 minutes after the administration of first dose of suspensions. Silymarin (100 mg/ kg b.w.) was used as a standard hepatoprotective drug for comparison.
Forty-eight hours after aflatoxin administration blood was collected from retro-orbital plexus. The blood samples were allowed to clot for 15 minutes at room temperature. Serum was separated by centrifugation at 2500 rpm for 15 minutes and analyzed for biochemical parameters such as serum glutamic oxaloacetate transaminase (SGOT) and serum glutamic pyruvic transaminase (SGPT) (14), alkaline Values are expressed as mean ± SEM. Aflatoxin group was compared with control group. Test extract groups were compared with aflatoxin group. **p<0.01; ***p<0.001; NS = Non Significant. Values in parenthesis indicate the % reduction in relation to the aflatoxin group.
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phosphatase (ALP) (15) and total bilirubin (T.Bil.) (16) . Liver from one animal of each group was isolated to study the histopathological changes.
Results of the biochemical estimations are reported as mean ± standard error of mean (SEM). Total variations, present in a set of data was estimated by one-way analysis of variance (ANOVA), Student's 't'-test was used for determining significance.
RESULTS
Rats treated with aflatoxin developed significant liver damage as observed from elevated serum levels of hepato-specific enzymes ( Table 1) . Activities of SGPT, SGOT and ALP in serum were increased in aflatoxin-intoxicated rats. A marked elevation in the concentration of bilirubin, was observed in the hepatotoxin-treated rats. Treatment with ethanolic leaf extracts of T. portulacastrum showed a significant protection against aflatoxin-induced alterations in the serum enzyme levels and bilirubin. Table 1 shows that ethanol extract in dose dependent manner decreasing the increased levels of SGPT, SGOT, ALP and total bilirubin due to aflatoxin. Minimum effective dose was found to be 100mg/ kg. The degree of protection was observed maximally with the highest dose of the T. portulacastrum (i.e., 800 mg/kg body weight). Results obtained indicate the phytotherapeutic option offers comparable protection to aflatoxin induced liver damage as compared to silymarin (Table 1) .
Histopathological examination revealed hepatic degeneration, necrosis and fatty infiltration in aflatoxin treated rats indicating liver damage (Fig I) . Rats treated with ethanolic leaf extracts of T. portulacastrum and Silymarin showed less necrosis and normal histoarchitecture compared to aflatoxin indicating hepatoprotective effect of phytotherapeutic option (Fig II) .
DISCUSSION
The levels of number of hepatic enzymes are used as diagnostic indicators of hepatic injury. SGOT, SGPT and serum bilirubin are the most sensitive tests employed in the diagnosis of hepatic diseases (17, 18) . Elevated levels of serum enzymes are indicative of cellular leakage and loss of functional integrity of the cell membrane in liver (19, 20) . Administration of aflatoxin significantly raises the serum level of enzymes like SGPT and SGOT in rats as observed in our results.
Oral administration of ethanolic leaf extracts of T. portulacastrum at doses of 50-800 mg/kg body weight to rats caused a decrease in the activity of marker enzymes in serum in dose dependent manner, which may be a consequence of the stabilization of plasma membrane as well as repair of hepatic tissue damage caused by aflatoxin. The activity of serum alkaline phosphatase was also elevated during aflatoxin administration. Alkaline phosphatase is excreted normally via bile by the liver. In liver injury due to hepatotoxin, there is a defective excretion of bile by the liver which is reflected in their increased levels in serum (21) (22) (23) .
Hyperbilirubinaemia is a very sensitive test to substantiate the functional integrity of the liver and severity of necrosis which increases the binding, conjugating and excretory capacity of hepatocytes that is proportional to the erythrocyte degeneration rate (24, 25 ). Depletion of elevated bilirubin level together with the suppression of the activity of ALP in the serum of rats treated with ethanolic leaf extracts of T. portulacastrum suggests the possibility of phytotherapeutic option being able to stabilize biliary dysfunction of rat liver during chronic injury with aflatoxin. Results obtained from histopathological study also shown signs of recovery from aflatoxin hepatotoxicity. The hepatoprotective activity of phytotherapeutic option against aflatoxin may be due to inhibitory effects on formation of the active metabolite which in turn reduces drugmetabolizing enzymes and actively and specifically binds to RNA polymerases and thereby inhibits the nucleic acid and protein synthesis (26) .
The probable mechanism by which T. portulacastrum L. exerts its protective action against aflatoxin-induced hepatocellular metabolic alterations could be by the stimulation of hepatic regeneration through an improved synthesis of protein or accelerated detoxification and excretion. Which of these possibilities are the major factors(s) for the hepatoprotective role of T. portulacastrum L. are being studied in our laboratory.
The T. portulacastrum L. contains an alkaloid trianthemine, ecdysterone (a potent chemosterilant) (9, 27) , saponin and punarnavine (28) . However, the exact mechanism of action can only be explained when active principles are isolated and tested against hepatotoxins. Thus, our results conclude that the ethanolic leaf extract of T. portulacastrum has a protective effect in an animal model of aflatoxin-induced hepatic damage in rats.
